Mediolanum International Funds Ltd Grows Position in DocuSign, Inc. (NASDAQ:DOCU)

Mediolanum International Funds Ltd lifted its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 25.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 158,993 shares of the company’s stock after buying an additional 32,245 shares during the period. Mediolanum International Funds Ltd owned approximately 0.08% of DocuSign worth $14,544,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Modus Advisors LLC purchased a new stake in shares of DocuSign in the fourth quarter valued at about $36,000. Itau Unibanco Holding S.A. acquired a new position in DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign in the 3rd quarter valued at approximately $33,000. Avior Wealth Management LLC increased its holdings in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after buying an additional 145 shares during the last quarter. Finally, Friedenthal Financial purchased a new stake in shares of DocuSign during the 4th quarter valued at approximately $54,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Wells Fargo & Company increased their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Friday, December 6th. HSBC reissued a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Hsbc Global Res raised shares of DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Robert W. Baird lifted their price target on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Finally, Morgan Stanley upped their price objective on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $92.45.

DocuSign Trading Up 0.9 %

Shares of NASDAQ DOCU opened at $96.73 on Friday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The stock has a market cap of $19.54 billion, a P/E ratio of 19.94, a PEG ratio of 8.63 and a beta of 0.88. The business’s fifty day simple moving average is $91.05 and its 200-day simple moving average is $72.58.

Insider Buying and Selling at DocuSign

In other DocuSign news, Director Peter Solvik sold 10,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the sale, the director now directly owns 150,253 shares of the company’s stock, valued at approximately $13,712,088.78. This represents a 6.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the sale, the director now owns 7,736 shares in the company, valued at $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 685,773 shares of company stock valued at $66,032,726 in the last quarter. Corporate insiders own 1.66% of the company’s stock.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.